Stay Updated on the Latest in Oncology
Stay ahead with the latest FDA approvals, groundbreaking innovations, and collaborative advancements in oncology. Get real-time updates on major conferences along with expert insights and key highlights shaping the future of cancer care.
Recent Insights
Discover the latest trends in cancer care.
Breakthroughs in Bladder Cancer: Key Highlights from ASCO GU 2025
Key Takeaways Trial Updates: Antibody-Drug Conjugates (ADCs): Future Outlook: 26 February 2025 ASCO GU 2025 Symposium was a pivotal event in the landscape of bladder
US FDA approves Amgen’s colorectal cancer therapy: Lumakras (Sotorasib) and Vectibix (Panitumumab) for Metastatic Colorectal Cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen’s combination therapy of Lumakras (sotorasib) and Vectibix (panitumumab) for treating metastatic colorectal cancer in patients
FDA Approval: Grafapex (Treosulfan) for Allogeneic Stem Cell Transplantation in adult and pediatric patients aged one year and older with AML or MDS
The FDA has approved Grafapex (treosulfan) in combination with fludarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in adult and pediatric
FDA Approves Trastuzumab Deruxtecan for Pretreated HER2-Low and -Ultralow Metastatic Breast Cancer
Key Highlights: Clinical Trial Findings: DESTINY-Breast06 The FDA’s decision was based on results from the phase 3 DESTINY-Breast06 trial (NCT04494425), which compared T-DXd with chemotherapy
Tumor DNA in Blood: A New Predictor of Lung Cancer Outcomes
ctDNA testing predicts lung cancer relapse, enabling personalized treatment and better outcomes.
Revolutionizing Cancer Treatment: CAR-NK Cell Therapy Offers New Hope for B-Cell Lymphoma
CAR-NK therapy offers a safer, more accessible alternative to CAR-T, using off-the-shelf natural killer cells to revolutionize cancer treatment with reduced toxicity and promising results.